{"id":"https://openalex.org/W2552091371","doi":"https://doi.org/10.1182/blood.v116.21.2788.2788","title":"A Phase I Study of Milatuzumab, a Humanized Anti-CD74 Antibody, and Veltuzumab, a Humanized Anti-CD20 Antibody, In Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma.","display_name":"A Phase I Study of Milatuzumab, a Humanized Anti-CD74 Antibody, and Veltuzumab, a Humanized Anti-CD20 Antibody, In Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma.","publication_year":2010,"publication_date":"2010-11-19","ids":{"openalex":"https://openalex.org/W2552091371","doi":"https://doi.org/10.1182/blood.v116.21.2788.2788","mag":"2552091371"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v116.21.2788.2788","doi":"https://doi.org/10.1182/blood.v116.21.2788.2788","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v116.21.2788.2788","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104068814","display_name":"Beth A. Christian","orcid":"https://orcid.org/0009-0008-6077-3669","observed_orcids":["https://orcid.org/0009-0008-6077-3669"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Beth Christian","raw_affiliation_strings":["Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA,","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054730003","display_name":"Lapo Alinari","orcid":"https://orcid.org/0000-0002-8870-4162","observed_orcids":["https://orcid.org/0000-0002-8870-4162"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lapo Alinari","raw_affiliation_strings":["Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA,","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040109763","display_name":"Christian Tyler Earl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Christian Tyler Earl","raw_affiliation_strings":["Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA,","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010568429","display_name":"Emily E. Wilding","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Emily Wilding","raw_affiliation_strings":["Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA,","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050743862","display_name":"Carl D. Quinion","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Carl Quinion","raw_affiliation_strings":["Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA,","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039845129","display_name":"Mark E. Lustberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mark Lustberg","raw_affiliation_strings":["Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA,","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112786802","display_name":"Don M. Benson","orcid":"https://orcid.org/0000-0001-8837-0548","observed_orcids":["https://orcid.org/0000-0001-8837-0548"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Don M Benson","raw_affiliation_strings":["Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA,","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102896676","display_name":"Jeffrey Alan Jones","orcid":"https://orcid.org/0000-0001-9557-0820","observed_orcids":["https://orcid.org/0000-0001-9557-0820"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey A. Jones","raw_affiliation_strings":["Comprehensive Cancer Center, The Ohio State University, Columbus, OH,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center, The Ohio State University, Columbus, OH,","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000921376","display_name":"John C. Byrd","orcid":"https://orcid.org/0000-0001-9830-0711","observed_orcids":["https://orcid.org/0000-0001-9830-0711"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John C. Byrd","raw_affiliation_strings":["Comprehensive Cancer Center, The Ohio State University, Columbus, OH,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center, The Ohio State University, Columbus, OH,","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014083764","display_name":"William A. Wegener","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126919","display_name":"Immunomedics (United States)","ror":"https://ror.org/02pf50490","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126919"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William A. Wegener","raw_affiliation_strings":["Clinical Research, Immunomedics, Inc., Morris Plains, NJ, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research, Immunomedics, Inc., Morris Plains, NJ, USA,","institution_ids":["https://openalex.org/I4210126919"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003890903","display_name":"David M. Goldenberg","orcid":"https://orcid.org/0000-0001-5539-421X","observed_orcids":["https://orcid.org/0000-0001-5539-421X"]},"institutions":[{"id":"https://openalex.org/I4210131484","display_name":"Center for Molecular Medicine and Immunology","ror":"https://ror.org/03fhjvs31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210131484"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David M. Goldenberg","raw_affiliation_strings":["Center for Molecular Medicine and Immunology, Garden State Cancer Center, Belleville, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Molecular Medicine and Immunology, Garden State Cancer Center, Belleville, NJ, USA","institution_ids":["https://openalex.org/I4210131484"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012846289","display_name":"Robert A. Baiocchi","orcid":"https://orcid.org/0000-0002-1619-4853","observed_orcids":["https://orcid.org/0000-0002-1619-4853","https://orcid.org/0000-0002-6518-8169"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A. Baiocchi","raw_affiliation_strings":["Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA,","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056946123","display_name":"Kristie A. Blum","orcid":"https://orcid.org/0000-0001-7363-9794","observed_orcids":["https://orcid.org/0000-0001-7363-9794","https://orcid.org/0000-0003-4229-2569"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristie A. Blum","raw_affiliation_strings":["Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA,","institution_ids":["https://openalex.org/I52357470"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5010568429","https://openalex.org/A5039845129","https://openalex.org/A5040109763","https://openalex.org/A5050743862"],"corresponding_institution_ids":["https://openalex.org/I52357470"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":1.0851,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.7899806,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"116","issue":"21","first_page":"2788","last_page":"2788"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/veltuzumab","display_name":"veltuzumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.9990000128746033},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.8930000066757202},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.9700000286102295},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.7730000019073486},{"id":"https://openalex.org/keywords/combination-antibody-therapy","display_name":"antibody combination therapy","score":0.6669999957084656},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8999999761581421},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7020000219345093},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.32600000500679016},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.5350000262260437}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8688173294067383},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6021289825439453},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.5633409023284912},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.484169065952301},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.45795121788978577},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.41141220927238464},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36072808504104614},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.3399164080619812},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3237382769584656},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2302810549736023}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v116.21.2788.2788","doi":"https://doi.org/10.1182/blood.v116.21.2788.2788","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v116.21.2788.2788","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8100000023841858}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4252257778","https://openalex.org/W2116675024","https://openalex.org/W2065239231","https://openalex.org/W2559780739","https://openalex.org/W2241007778","https://openalex.org/W4252950657","https://openalex.org/W2228370321","https://openalex.org/W2134264204","https://openalex.org/W6118472","https://openalex.org/W2029664590"],"abstract_inverted_index":{"Abstract":[0,1,13],"2788":[2],"Preclinical":[3],"studies":[4],"conducted":[5],"at":[6,165,186,195,260,509,517,526,538,547],"our":[7],"institution":[8],"(Alinari":[9],"et":[10],"al.":[11],"Blood":[12],"1694,":[14],"2009)":[15],"demonstrated":[16,96],"superior":[17],"efficacy":[18],"of":[19,50,94,138,193,204,264,281,299,338,381,405,444,459,551,588,645,691,703],"milatuzumab":[20,114,132,194,237,351,359,697],"(Immunomedics,":[21,59],"Inc.),":[22,60],"a":[23,61,136,152,279,311,391,506,536,667],"humanized":[24,63],"anti-CD74":[25],"antibody,":[26,65],"in":[27,31,46,87,100,117,143,156,388,400,436,453,485,639,700],"combination":[28,664],"with":[29,102,113,129,145,158,179,190,216,249,292,356,494,563,574,648],"rituximab":[30,74,130],"mantle":[32],"cell":[33,36,296],"lymphoma":[34,107],"(MCL)":[35],"lines,":[37],"MCL":[38],"patient":[39],"(pt)":[40],"primary":[41,670],"tumor":[42],"cells,":[43],"and":[44,83,104,131,148,175,198,210,219,226,229,234,267,276,326,363,365,374,387,409,428,432,441,447,463,468,475,477,520,541,577,582,609,635,659,696],"an":[45],"vivo":[47],"preclinical":[48],"model":[49],"human":[51],"MCL,":[52],"compared":[53,120],"to":[54,69,121,126,170,222,304,314,334,558,570,622,625,654,663,678],"either":[55,122],"agent":[56,98,123],"alone.":[57],"Veltuzumab":[58],"novel":[62],"anti-CD20":[64],"has":[66,321,567,673],"been":[67,332,413,451,568,674],"reported":[68],"have":[70,258,331,412,449],"several":[71],"advantages":[72],"over":[73],"including":[75,289,656],"slower":[76],"off-rates,":[77],"shorter":[78],"infusion":[79,344,378,471,479,495,561,633,675],"times,":[80],"higher":[81],"potency,":[82],"improved":[84],"therapeutic":[85],"responses":[86],"animal":[88],"models.":[89],"Phase":[90],"II":[91],"clinical":[92],"testing":[93],"veltuzumab":[95,111,147,184,224,266,470,695],"single":[97],"activity":[99,141],"pts":[101,157,213,248,277,291,340,367,403,439,534,554,624,647],"relapsed":[103,159,649],"refractory":[105,161,303,651],"non-Hodgkin's":[106,704],"(NHL).":[108],"In":[109,499,529,642],"vitro,":[110],"combined":[112,146,189,265],"also":[115,591],"resulted":[116],"enhanced":[118],"apoptosis":[119],"alone,":[124],"similar":[125],"that":[127,594],"observed":[128,142,333,418,560,671],"(Fig":[133],"1).":[134],"As":[135],"result":[137],"the":[139,172,315,350,500,530,559,565,595,602,628,632,692,701],"anti-tumor":[140],"vitro":[144],"milatuzumab,":[149,325,564],"we":[150],"initiated":[151],"phase":[153],"I/II":[154],"trial":[155],"or":[160,253,347,497,650],"B-cell":[162],"NHL":[163,652],"after":[164,235],"least":[166,261],"1":[167,353,362,389,443,474,512,521,542],"prior":[168,221,283,293],"therapy":[169],"determine":[171,626],"safety,":[173],"tolerability,":[174],"overall":[176],"response":[177,313],"rate":[178],"this":[180],"combination.":[181],"Patients":[182],"received":[183,214,278],"200":[185],"mg/m2":[187],"weekly":[188],"escalating":[191],"doses":[192],"8,":[196],"16,":[197],"20":[199,579],"mg/kg":[200,324,358,370],"twice":[201],"per":[202],"wk":[203],"wks":[205],"1\u20134,":[206],"12,":[207,364,448],"20,":[208,511],"28,":[209],"36.":[211],"All":[212],"pre-medication":[215],"acetominophen,":[217,227],"diphenhydramine,":[218,228],"famotidine":[220],"each":[223,236],"dose":[225,328],"hydrocortisone":[230],"50":[231],"mg":[232,580,584],"before":[233],"dose.":[238],"Dose":[239,319,605],"limiting":[240,329],"toxicity":[241,398,672],"was":[242,271,491,590],"defined":[243,306],"during":[244,346,360,371],"weeks":[245,263,361,372,445],"1\u20134.":[246],"Six":[247],"grade":[250,342,406,419],"2":[251,290,366,402,617],"(n=2)":[252],"3":[254,286,337,343,373,377,552,644],"(n=4)":[255],"follicular":[256],"NHL,":[257],"completed":[259],"4":[262,407,446],"milatuzumab.":[268,679],"Median":[269],"age":[270],"63.5":[272],"years":[273],"(range":[274,285],"44\u201381),":[275],"median":[280],"3.5":[282],"therapies":[284],"\u2013":[287],"5),":[288],"autologous":[294],"stem":[295],"transplant.":[297],"Three":[298],"6":[300,339,438,623,646],"patients":[301],"were":[302,422,465,488,555],"rituximab,":[305],"as":[307],"having":[308],"less":[309],"than":[310],"partial":[312],"last":[316],"rituximab-containing":[317],"regimen.":[318],"escalation":[320,606],"reached":[322],"16":[323,369],"no":[327,410,492,598],"toxicities":[330,421],"date.":[335],"However,":[336],"experienced":[341,514],"reactions":[345,379,496,562,634,676],"immediately":[348],"following":[349],"infusion;":[352],"pt":[354,504,513,522,543],"treated":[355,653],"8":[357],"receiving":[368],"12.":[375],"Grade":[376,395],"consisted":[380],"fever,":[382],"rigors,":[383],"nausea,":[384],"vomiting,":[385],"diarrhea,":[386],"case":[390],"diffuse":[392],"macular":[393],"rash.":[394],"3\u20134":[396],"hematologic":[397],"occurred":[399],"only":[401],"consisting":[404],"lymphopenia,":[408],"infections":[411],"observed.":[414],"The":[415,586,615,669,689],"most":[416],"frequently":[417],"1\u20132":[420],"fatigue,":[423],"transient":[424],"hyperglycemia,":[425],"dyspnea,":[426],"hypoalbuminemia,":[427],"thrombocytopenia.":[429],"Human":[430],"anti-veltuzumab":[431],"anti-milatuzumab":[433],"antibodies,":[434],"collected":[435],"all":[437],"pretreatment":[440],"day":[442,473,481],"not":[450],"detected":[452],"any":[454],"pt.":[455],"Plasma":[456],"cytokine":[457,486],"levels":[458,487],"IL-10,":[460],"IL-12,":[461],"TNF-\u03b1":[462],"INF-\u03b3":[464],"checked":[466],"pre-":[467,476],"post-":[469],"on":[472,480,601],"post-milatuzumab":[478],"2.":[482],"While":[483],"elevations":[484],"observed,":[489],"there":[490],"correlation":[493],"response.":[498],"first":[501,616],"cohort,":[502,532],"one":[503],"achieved":[505,535],"PR":[507,537],"maintained":[508],"week":[510,518,527,539,548],"stable":[515,545],"disease":[516,525,546],"10,":[519,540],"developed":[523],"progressive":[524],"20.":[528],"second":[531],"two":[533],"had":[544],"10.":[549],"Two":[550],"responding":[553,640],"rituximab-refractory.":[556],"Due":[557],"protocol":[566],"amended":[569],"include":[571],"additional":[572],"premedication":[573],"intravenous":[575],"antihistamine,":[576],"dexamethasone":[578],"pre-milatuzumab":[581],"10":[583],"post-milatuzumab.":[585],"schedule":[587],"treatment":[589,702],"modified":[592],"so":[593],"antibodies":[596,694],"are":[597],"longer":[599],"administered":[600],"same":[603],"day.":[604],"will":[607,612,619,630],"continue":[608],"updated":[610],"results":[611],"be":[613,620],"presented.":[614],"cohorts":[618],"expanded":[621],"if":[627],"modifications":[629],"limit":[631],"permit":[636],"prolonged":[637],"dosing":[638],"pts.":[641],"summary,":[643],"date":[655],"heavily":[657],"pretreated":[658],"rituximab-refractory":[660],"pts,":[661],"responded":[662],"therapy,":[665],"achieving":[666],"PR.":[668],"due":[677],"Disclosures:":[680],"Christian:":[681],"Immunomedics,":[682],"Inc.:":[683,711,715,719,723,727],"Research":[684,708,712,724,728],"Funding.":[685,709,713,725,729],"Off":[686],"Label":[687],"Use:":[688],"use":[690],"monoclonal":[693],"is":[698],"experimental":[699],"lymphoma.":[705],"Benson:Immunomedics,":[706],"Inc:":[707],"Jones:Immunomedics,":[710],"Wegener:Immunomedics,":[714],"Employment,":[716,720],"shareholders.":[717,721],"Goldenberg:Immunomedics,":[718],"Baiocchi:Immunomedics,":[722],"Blum:Immunomedics,":[726]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2016-11-30T00:00:00"}